Axonics Modulation Technologies raises $38.5M for device clinical study in overactive bladder patients
Roughly 100 million people in the U.S. and Europe are challenged with having an overactive bladder and 40 million with fecal control issues. An implant that stimulates the sacral nerves in the pelvis is a new option for treatment.
